Because of the extraordinary potential impact of Proposition 37 on US Food labeling, we follow this controversy closely. Both the EU's EFSA (Oct 4) and Germany's BfR (Oct 1) have published reviews that are sharply critical of the methodology and experimental design of the Seralini GMO maize carcinogenicity study. We note that the October 11 issue of Nature provides useful perspective (Nature, vol. 490, p. 158, 11 Oct 2012).

These reviews and the continuing controversy will, no doubt, be a factor in the current battle over California Proposition 37. See our June 15 and September 20 posts.

We post below: the EFSA Letter to Seralini, the EFSA Review, the BfR Press Release, and the BfR Review.